Pluto Bioinformatics

GSE57494: GPBAR1 agonism has a broad impact on blocking macrophage activation

Bulk RNA sequencing

Human D14+ / CD16+ monocytes were treated with GPBAR1 agonists or controls, and were stimulated with interferon gamma and LPS. At 6 and 24 hours, the cells were profiled by RNAseq SOURCE: Jonathan,Daryl,Hill (jon.hill@boehringer-ingelheim.com) - Boehringer Ingelheim Pharmaceuticals Inc